Plain-English translation of NCT06263088 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
EQUITY GI is a research study designed to understand and reduce unfair differences in cancer care that Black patients with digestive cancers experience. The study will collect information about patients' cancer diagnosis, treatment, and outcomes to find where care could be improved, and will create tools and programs to help doctors provide better, more equal care for all patients.
Black patients with digestive cancers like colon, rectal, and pancreatic cancer have worse outcomes and receive less aggressive treatment than white patients—even today. This study exists to identify exactly where these gaps happen and to build practical solutions that doctors can use to make sure all patients get the best possible care.
You likely qualify if…
You likely don't qualify if…
Your participation involves sharing your medical information and records related to your cancer diagnosis and treatment. The study team will gather data about your cancer type, staging, treatments received, and health outcomes over time. You'll also be asked questions about your experiences with healthcare and your needs for support—helping researchers understand what barriers you faced and what would help future patients like you.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
United States